JPS6233209B2 - - Google Patents

Info

Publication number
JPS6233209B2
JPS6233209B2 JP51068676A JP6867676A JPS6233209B2 JP S6233209 B2 JPS6233209 B2 JP S6233209B2 JP 51068676 A JP51068676 A JP 51068676A JP 6867676 A JP6867676 A JP 6867676A JP S6233209 B2 JPS6233209 B2 JP S6233209B2
Authority
JP
Japan
Prior art keywords
udp
present
experimental example
mice
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51068676A
Other languages
English (en)
Japanese (ja)
Other versions
JPS52151732A (en
Inventor
Masanori Fukui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP6867676A priority Critical patent/JPS52151732A/ja
Publication of JPS52151732A publication Critical patent/JPS52151732A/ja
Publication of JPS6233209B2 publication Critical patent/JPS6233209B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP6867676A 1976-06-14 1976-06-14 Prophylactic and therapeutic agent against bacterial Granted JPS52151732A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6867676A JPS52151732A (en) 1976-06-14 1976-06-14 Prophylactic and therapeutic agent against bacterial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6867676A JPS52151732A (en) 1976-06-14 1976-06-14 Prophylactic and therapeutic agent against bacterial

Publications (2)

Publication Number Publication Date
JPS52151732A JPS52151732A (en) 1977-12-16
JPS6233209B2 true JPS6233209B2 (enrdf_load_html_response) 1987-07-20

Family

ID=13380545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6867676A Granted JPS52151732A (en) 1976-06-14 1976-06-14 Prophylactic and therapeutic agent against bacterial

Country Status (1)

Country Link
JP (1) JPS52151732A (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf

Also Published As

Publication number Publication date
JPS52151732A (en) 1977-12-16

Similar Documents

Publication Publication Date Title
Maller et al. A study of amikacin given once versus twice daily in serious infections
US4626536A (en) Compositions for combatting toxaemia
Hoeprich Clinical use of amphotericin B and derivatives: lore, mystique, and fact
BG60934B2 (bg) Терапевтични състави,съдържащи антрациклинови глюкозиди
JPS61268625A (ja) ポリエン抗生物質エマルジヨン製剤
Utz et al. Amphotericin B toxicity: combined clinical staff conference at the National Institutes of Health
CZ2002291A3 (cs) Farmaceuticky stabilní přípravek oxaliplatiny k parenterální aplikaci
KR20060096411A (ko) 테트로도톡신의 안정한 동결건조 제약 제제
WO1991002529A2 (en) Product and method for killing abnormal vertebrate cells
HK93990A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
Kapusnik et al. Challenging conventional aminoglycoside dosing regimens: the value of experimental models
JPS6233209B2 (enrdf_load_html_response)
JP2621255B2 (ja) アントラサイクリングリコシド溶液およびその製造方法
US4343799A (en) Use of derivatives of 6α-methylprednisolone for the prevention or reduction of adriamycin-induced cardiotoxicity
Kuhn et al. Autoradiographic evidence for penetration of 3H-ceftriaxone (Rocephin®) into cells of spleen, liver and kidney of mice
JPS6233208B2 (enrdf_load_html_response)
Vischer et al. Rifampicin against experimental listeriosis in the mouse
BENNETT Review of selected aspects of pharmacology
VALL-SPINOSA et al. Rifampin: Characteristics and role in the chemotherapy of tuberculosis
Zinner et al. Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model
Pines et al. A comparison of pivampicillin and ampicillin in exacerbations of chronic bronchitis
JP3022915B2 (ja) 癌転移抑制剤
Grogan Pseudomonas aeruginosa infection in mice after treatment with cyclophosphamide
Lichtenstein et al. A controlled study of isoniazid and iproniazid